SARS-CoV-2 evades natural killer cell cytotoxic responses

In a recent study posted to the bioRxiv* preprint server, researchers at Stanford University School of Medicine revealed the mechanism via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escapes natural killer (NK) cell cytotoxic reactions.

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients

COVID-19: Immunology, vaccines and epidemiology: Week 2: 1.5 - OpenLearn - Open University

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients - Hagemann - 2022 - European Journal of Immunology - Wiley Online Library

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity, Virology Journal

Off balance: Interferons in COVID-19 lung infections - eBioMedicine

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Immune system evasion – the HIV-infected cell

Immune Response to HIV Immunology Mini Review

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

The Emergence of NK Cell-Based Treatment in Cancer Immunotherapy

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update - Jasim - 2022 - Journal of Medical Virology - Wiley Online Library